These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16046297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians.
    Yadav AK, Sinha N, Kumar V, Bhansali A, Dutta P, Jha V.
    Indian J Med Res; 2016 Jul; 144(1):32-37. PubMed ID: 27834323
    [Abstract] [Full Text] [Related]

  • 4. [Carnosine, carnosinase and kidney diseases].
    Kiliś-Pstrusińska K.
    Postepy Hig Med Dosw (Online); 2012 Apr 20; 66():215-21. PubMed ID: 22706107
    [Abstract] [Full Text] [Related]

  • 5. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
    Ahluwalia TS, Lindholm E, Groop LC.
    Diabetologia; 2011 Sep 20; 54(9):2295-302. PubMed ID: 21573905
    [Abstract] [Full Text] [Related]

  • 6. The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
    Kurashige M, Imamura M, Araki S, Suzuki D, Babazono T, Uzu T, Umezono T, Toyoda M, Kawai K, Imanishi M, Hanaoka K, Maegawa H, Uchigata Y, Hosoya T, Maeda S.
    PLoS One; 2013 Sep 20; 8(1):e54064. PubMed ID: 23342076
    [Abstract] [Full Text] [Related]

  • 7. A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.
    Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA.
    Diabetes; 2007 Sep 20; 56(9):2410-3. PubMed ID: 17601991
    [Abstract] [Full Text] [Related]

  • 8. Association between CNDP1 genotype and diabetic nephropathy is sex specific.
    Mooyaart AL, Zutinic A, Bakker SJ, Grootendorst DC, Kleefstra N, van Valkengoed IG, Böhringer S, Bilo HJ, Dekker FW, Bruijn JA, Navis G, Janssen B, Baelde HJ, De Heer E.
    Diabetes; 2010 Jun 20; 59(6):1555-9. PubMed ID: 20332346
    [Abstract] [Full Text] [Related]

  • 9. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.
    Diabetes; 2008 Sep 20; 57(9):2547-51. PubMed ID: 18753673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
    Everaert I, Taes Y, De Heer E, Baelde H, Zutinic A, Yard B, Sauerhöfer S, Vanhee L, Delanghe J, Aldini G, Derave W.
    Am J Physiol Renal Physiol; 2012 Jun 15; 302(12):F1537-44. PubMed ID: 22496410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Global Cndp1-Knock-Out Selectively Increases Renal Carnosine and Anserine Concentrations in an Age- and Gender-Specific Manner in Mice.
    Weigand T, Colbatzky F, Pfeffer T, Garbade SF, Klingbeil K, Colbatzky F, Becker M, Zemva J, Bulkescher R, Schürfeld R, Thiel C, Volk N, Reuss D, Hoffmann GF, Freichel M, Hecker M, Poth T, Fleming T, Poschet G, Schmitt CP, Peters V.
    Int J Mol Sci; 2020 Jul 10; 21(14):. PubMed ID: 32664451
    [Abstract] [Full Text] [Related]

  • 14. Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.
    Albrecht T, Schilperoort M, Zhang S, Braun JD, Qiu J, Rodriguez A, Pastene DO, Krämer BK, Köppel H, Baelde H, de Heer E, Anna Altomare A, Regazzoni L, Denisi A, Aldini G, van den Born J, Yard BA, Hauske SJ.
    Sci Rep; 2017 Mar 10; 7():44492. PubMed ID: 28281693
    [Abstract] [Full Text] [Related]

  • 15. Carnosine and Diabetic Nephropathy.
    Peters V, Yard B, Schmitt CP.
    Curr Med Chem; 2020 Mar 10; 27(11):1801-1812. PubMed ID: 30914013
    [Abstract] [Full Text] [Related]

  • 16. Intrinsic carnosine metabolism in the human kidney.
    Peters V, Klessens CQ, Baelde HJ, Singler B, Veraar KA, Zutinic A, Drozak J, Zschocke J, Schmitt CP, de Heer E.
    Amino Acids; 2015 Dec 10; 47(12):2541-50. PubMed ID: 26206726
    [Abstract] [Full Text] [Related]

  • 17. Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
    Peters V, Schmitt CP, Zschocke J, Gross ML, Brismar K, Forsberg E.
    Amino Acids; 2012 Jun 10; 42(6):2411-6. PubMed ID: 21833769
    [Abstract] [Full Text] [Related]

  • 18. Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
    Peters V, Zschocke J, Schmitt CP.
    J Inherit Metab Dis; 2018 Jan 10; 41(1):39-47. PubMed ID: 29027595
    [Abstract] [Full Text] [Related]

  • 19. Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.
    Zhang S, Albrecht T, Rodriguez-Niño A, Qiu J, Schnuelle P, Peters V, Schmitt CP, van den Born J, Bakker SJL, Lammert A, Krämer BK, Yard BA, Hauske SJ.
    Amino Acids; 2019 Apr 10; 51(4):611-617. PubMed ID: 30610469
    [Abstract] [Full Text] [Related]

  • 20. L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.
    Sauerhöfer S, Yuan G, Braun GS, Deinzer M, Neumaier M, Gretz N, Floege J, Kriz W, van der Woude F, Moeller MJ.
    Diabetes; 2007 Oct 10; 56(10):2425-32. PubMed ID: 17601992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.